168 related articles for article (PubMed ID: 25169523)
1. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
Yan YL; Han F; Tan WM; Wu CP; Qin X
Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
[TBL] [Abstract][Full Text] [Related]
2. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
[TBL] [Abstract][Full Text] [Related]
3. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
Kong Q; Li P; Tian Q; Ha MW
Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
[TBL] [Abstract][Full Text] [Related]
4. Current evidence on the relationship between murine double minute 2 T309G polymorphism and esophageal cancer susceptibility.
Chen B; Xiong MM; Meng XL
Dis Esophagus; 2015; 28(6):593-601. PubMed ID: 24844868
[TBL] [Abstract][Full Text] [Related]
5. MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.
Liu J; Zheng Y; Lei D; Liu D; Xu F; Jin T; Cao X; Zhao X; Yu X; Pan X
Asian Pac J Cancer Prev; 2011; 12(8):1899-903. PubMed ID: 22292622
[TBL] [Abstract][Full Text] [Related]
6. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
[TBL] [Abstract][Full Text] [Related]
7. The Relationship Between MDM2 T309G Polymorphism and Leukemia in the Chinese Population: Evidence from a Meta-Analysis.
Zhao D; Liu T
Clin Lab; 2017 Oct; 63(10):1639-1645. PubMed ID: 29035454
[TBL] [Abstract][Full Text] [Related]
8. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
10. An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.
Qin X; Peng Q; Tang W; Lao X; Chen Z; Lai H; Deng Y; Mo C; Sui J; Wu J; Zhai L; Yang S; Li S; Zhao J
PLoS One; 2013; 8(9):e76031. PubMed ID: 24098760
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
[TBL] [Abstract][Full Text] [Related]
12. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.
Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF
Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988
[TBL] [Abstract][Full Text] [Related]
13. The MDM2 T309G polymorphism and risk of lung cancer: an updated meta-analysis of 10,186 cases and 14,155 controls.
Tian X; Wang B; Guo J; Liu X; Zhang T; Liang C; Zhou N; Hou X; Ma Y; Yu H; Chen L; Ren Z; Fan K; Tian Q
Panminerva Med; 2016 Dec; 58(4):341-348. PubMed ID: 27171940
[TBL] [Abstract][Full Text] [Related]
14. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
[TBL] [Abstract][Full Text] [Related]
15. MDM2 SNP309 variation increases cervical cancer risk among Asians.
Zhuo X; Ren J; Li D; Wu Y; Zhou Q
Tumour Biol; 2014 Jun; 35(6):5331-7. PubMed ID: 24532430
[TBL] [Abstract][Full Text] [Related]
16. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
Chen T; Yi SH; Liu XY; Liu ZG
Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
[TBL] [Abstract][Full Text] [Related]
18. Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.
Yan Y; Liang H; Xie L; He Y; Li M; Li R; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):2191-7. PubMed ID: 24142546
[TBL] [Abstract][Full Text] [Related]
19. The T309G murine double minute 2 gene polymorphism is an independent prognostic factor for patients with renal cell carcinoma.
de Martino M; Taus C; Wessely IS; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
DNA Cell Biol; 2015 Feb; 34(2):107-12. PubMed ID: 25415135
[TBL] [Abstract][Full Text] [Related]
20. MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis.
Fang F; Yu XJ; Yu L; Yao L
Med Oncol; 2011 Dec; 28(4):981-5. PubMed ID: 20503107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]